Literature DB >> 12839262

Synthesis and degradation of endothelin-1.

P D'Orléans-Juste1, M Plante, J C Honoré, E Carrier, J Labonté.   

Abstract

The endothelin-converting enzyme (ECE) is the main enzyme responsible for the genesis of the potent pressor peptide endothelin-1 (ET-1). It is suggested that the ECE is pivotal in the genesis of ET-1, considering that the knockout of both genes generates the same lethal developments during the embryonic stage. Several isoforms of the ECE have been disclosed, namely ECE-1, ECE-2, and ECE-3. Within each of the first two groups, several sub-isoforms derived through splicing of single genes have also been identified. In this review, the characteristics of each sub-isoform for ECE-1 and 2 will be discussed. It is important to mention that the ECE is, however, not the sole enzyme involved in the genesis of endothelins. Indeed, other moieties, such as chymase and matrix metalloproteinase II, have been suggested to be involved in the production of ET intermediates, such as ET-1 (1-31) and ET-1 (1-32), respectively. Other enzymes, such as the neutral endopeptidase 24-11, is curiously not only involved in the degradation and inactivation of ET-1, but is also responsible for the final production of the peptide via the hydrolysis of ET-1 (1-31). In this review, we will attempt to summarize, through the above-mentioned characteristics, the current wisdom on the role of these different enzymes in the genesis and termination of effect of the most potent pressor peptide reported to date.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12839262     DOI: 10.1139/y03-032

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  18 in total

1.  Another weapon against amyloid.

Authors:  David A Greenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-16       Impact factor: 11.205

Review 2.  Physiology of endothelin and the kidney.

Authors:  Donald E Kohan; Edward W Inscho; Donald Wesson; David M Pollock
Journal:  Compr Physiol       Date:  2011-04       Impact factor: 9.090

3.  Regulation of vascular contractility and blood pressure by the E2F2 transcription factor.

Authors:  Junlan Zhou; Yan Zhu; Min Cheng; Deepika Dinesh; Tina Thorne; Kian Keong Poh; Dongxu Liu; Chantal Botros; Yao Liang Tang; Nichole Reisdorph; Raj Kishore; Douglas W Losordo; Gangjian Qin
Journal:  Circulation       Date:  2009-09-14       Impact factor: 29.690

Review 4.  Regulation of blood pressure and salt homeostasis by endothelin.

Authors:  Donald E Kohan; Noreen F Rossi; Edward W Inscho; David M Pollock
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

Review 5.  Endothelin-1 in the pathophysiology of obesity and insulin resistance.

Authors:  Haley N Jenkins; Osvaldo Rivera-Gonzalez; Yann Gibert; Joshua S Speed
Journal:  Obes Rev       Date:  2020-07-06       Impact factor: 9.213

Review 6.  Endothelin and hepatic wound healing.

Authors:  Al-karim Khimji; Don C Rockey
Journal:  Pharmacol Res       Date:  2011-03-21       Impact factor: 7.658

7.  PKCepsilon increases endothelin converting enzyme activity and reduces amyloid plaque pathology in transgenic mice.

Authors:  Doo-Sup Choi; Dan Wang; Gui-Qui Yu; Guofen Zhu; Viktor N Kharazia; J Peter Paredes; Wesley S Chang; Jason K Deitchman; Lennart Mucke; Robert O Messing
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-12       Impact factor: 11.205

Review 8.  Contrasting actions of endothelin ET(A) and ET(B) receptors in cardiovascular disease.

Authors:  Markus P Schneider; Erika I Boesen; David M Pollock
Journal:  Annu Rev Pharmacol Toxicol       Date:  2007       Impact factor: 13.820

9.  Pivotal role of mouse mast cell protease 4 in the conversion and pressor properties of Big-endothelin-1.

Authors:  Martin Houde; Marc-David Jamain; Julie Labonté; Louisane Desbiens; Gunnar Pejler; Michael Gurish; Shinji Takai; Pedro D'Orléans-Juste
Journal:  J Pharmacol Exp Ther       Date:  2013-04-17       Impact factor: 4.030

Review 10.  Role of collecting duct endothelin in control of renal function and blood pressure.

Authors:  Donald E Kohan
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-08-28       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.